S. Soverini, S. Colarossi, A. Gnani, et al. Contribution of ABL kinase domain mutations to imatinib resistance in different subsets of Philadelphia-positive patients: By the GIMEMA working party on chronic myeloid leukemia. Clinical Cancer Research, 2006, 12(24): 7374-7379.

伊马替尼和尼洛替尼治疗慢性粒细胞白血病的疗效比较研究
Observation of Imatinib and Nilotinib in the Treatment of Chronic Myeloid Leukemia

王宇瑶, 杨 洁, 李 杰, 王瑞仓, 袁 军, 李 燕, 张晓霞, 郝洪岭   

世界肿瘤研究Vol.9 No.2, 全文下载: PDF HTML XML DOI:10.12677/WJCR.2019.92010, April 9 2019

慢性髓细胞白血病对伊马替尼产生耐药性的机制
Imatinib Resistance Mechanism on Chronic Myeloid Leukemia

夏君燕, 朱 平   

世界肿瘤研究Vol.2 No.3, 全文下载: PDF HTML XML DOI:10.12677/WJCR.2012.23003, July 26 2012

原发耐药急性髓系白血病伴费城染色体阳性一例并文献复习
A Case of Philadelphia Chromosome-Positive Acute Myeloid Leukemia (Ph+AML) of Primary Drug Resistance and Relevant Literature Review

王梦莹, 许 晗, 冯献启   

世界肿瘤研究Vol.11 No.4, 全文下载: PDF HTML XML DOI:10.12677/WJCR.2021.114016, September 29 2021

费城染色体阳性急性淋巴细胞白血病治疗进展
Progress in the Treatment of Philadelphia Chromosome Positive Acute Lymphocytic Leukemia

杜小飞, 江 明   

临床医学进展Vol.13 No.3, 全文下载: PDF HTML XML DOI:10.12677/ACM.2023.133513, March 15 2023

奥雷巴替尼治疗慢性髓系白血病的研究进展
Research Progress of Olverembatinib in the Treatment of Chronic Myeloid Leukemia

余 甜, 余 涛   

临床医学进展Vol.13 No.8, 全文下载: PDF HTML XML DOI:10.12677/ACM.2023.1381727, August 9 2023

博舒替尼治疗慢性粒细胞白血病现状
Current Situation of Bosutinib in the Treatment of Chronic Myeloid Leukemia

余艳玲, 余 涛, 余 甜, 万茜茜   

临床医学进展Vol.13 No.1, 全文下载: PDF HTML XML DOI:10.12677/ACM.2023.131014, January 6 2023